StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Share of Total Net Sales by Quarter

Share of Total Net Sales (%) (%)

QuarterlyAnnual

Novartis Share of Total Net Sales: 44.0% in Q3 2026, up 1.0 pts from a year earlier.

Latest, Q3 2026
44.0%
Period ended Sep 30, 2026
Change on a year earlier
+1.0 pts
43.0% in Q3 2025
History
30 quarters
Since Q2 2019
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

“|| United States | 6 429 | 6 036 | 7 | 7 | 44 | 43”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShare of Total Net Sales (%) (%)Year on yearSource
Q3 2026Sep 30, 202644.0%+1.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202641.0%-3.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202638.0%-5.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202540.0%-6.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202543.0%+1.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 202544.0%+3.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 202543.0%+4.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 202446.0%+4.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 202442.0%+3.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 202441.0%+2.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 202439.0%+1.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 202342.0%+2.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 202339.0%0.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 202339.0%+6.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 202338.0%+5.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 202240.0%+7.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis Share of Total Net Sales (%), quarterly Q2 2019–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-us-share-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.